MIC/B12 and Mega Burn are used for metabolism and weight-loss support
Mit der Zulassung der GLP-1-RA zur Behandlung von Adipositas hat deren Einsatz als Teil der multimodalen Therapie zur Gewichtsreduktion weiter an Bedeutung gewonnen
2a, b), which was comparable to that observed in the livers of HFD-fed mice (Fig
In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you
GLP-1 testing becomes relevant at this step
